Pre-engraftment neurological impairment in allogeneic stem cell transplant: A case report of atypical posterior reversible encephalopathy syndrome with pontine involvement

In the present report, we describe the case of a 59-year-old female who developed pre-engraftment multiple organ failure (MOF) after allogeneic hematopoietic stem cell transplant (HSCT), followed a few days later by a cohort of neurological symptoms leading to a diagnosis of posterior reversible enc...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in transplantation 2023-01, Vol.1, p.1089995
Main Authors: Acerbis, Andrea, Orofino, Giorgio, Campodonico, Edoardo, Del Poggio, Anna, Xue, Elisabetta, di Matteo, Francesca, Spelta, Greta, Bruno, Alessandro, Falini, Andrea, Ciceri, Fabio, Peccatori, Jacopo, Greco, Raffaella
Format: Article
Language:English
Subjects:
Transplantation
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In the present report, we describe the case of a 59-year-old female who developed pre-engraftment multiple organ failure (MOF) after allogeneic hematopoietic stem cell transplant (HSCT), followed a few days later by a cohort of neurological symptoms leading to a diagnosis of posterior reversible encephalopathy syndrome (PRES). The diagnosis was achieved by excluding more frequent entities associated with neurological symptoms in HSCT and supported by compatible magnetic resonance imaging (MRI) findings, with remarkably interesting less frequent pontine involvement. GvHD prophylaxis, including sirolimus and mycophenolate mofetil (MMF), was discontinued, while carefully controlling blood pressure. In addition, high-dose steroids were employed. After 2 weeks, the neurological symptoms abated, and follow-up MRI showed a complete regression of neurological alterations, confirming the diagnostic hypothesis of PRES.
ISSN:2813-2440
2813-2440
DOI:10.3389/frtra.2022.1089995